North America Artificial Intelligence In Cardiology Market Size, Share & Industry Analysis Report By Component, By Application, (Diagnosis, Prediction, Drug Discovery, and Other Application). By Medical Condition (Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition), By Country and Growth Forecast, 2025 - 2032

The North America Artificial Intelligence In Cardiology Market would witness market growth of 31.7% CAGR during the forecast period (2025-2032).

The US market dominated the North America Artificial Intelligence In Cardiology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $5,768.5 million by 2032. The Canada market is experiencing a CAGR of 35% during (2025 - 2032). Additionally, The Mexico market would exhibit a CAGR of 33.7% during (2025 - 2032).

Artificial Intelligence (AI) is reshaping the landscape of cardiology, heralding a transformative era in cardiovascular healthcare by leveraging advanced computational techniques to enhance diagnostic precision, optimize treatment strategies, and improve patient outcomes. The integration of AI into cardiology is driven by the urgent need to address the global burden of cardiovascular diseases (CVDs), which remain the leading cause of morbidity and mortality worldwide.

AI’s applications in cardiology span a wide range of clinical and research domains, revolutionizing how cardiovascular conditions are diagnosed, monitored, and treated. One of the most prominent applications is in diagnostic imaging, where AI-powered algorithms enhance the interpretation of echocardiograms, computed tomography (CT) scans, magnetic resonance imaging (MRI), and nuclear imaging. These tools analyze complex imaging data to detect conditions such as coronary artery disease (CAD), valvular heart disease, and cardiomyopathies with remarkable accuracy.

North America represents one of the most advanced and rapidly evolving markets for Artificial Intelligence (AI) in Cardiology, driven by a confluence of technological innovation, robust healthcare infrastructure, and a high prevalence of cardiovascular diseases. The region comprises major markets like the United States, Canada, and Mexico, alongside smaller but emerging markets in the Caribbean and Central America. Cardiovascular diseases remain a leading cause of death across North America, underscoring the critical need for improved diagnostic accuracy, timely interventions, and personalized treatment options.

AI technologies—including machine learning, deep learning, natural language processing, and predictive analytics—are increasingly integrated into cardiology to enhance clinical decision-making, automate image interpretation, and facilitate remote patient monitoring. The adoption of AI is supported by significant investments from both the public and private sectors, with a strong emphasis on research and development, regulatory frameworks, and collaborations between healthcare providers and technology firms. Market trends in this region focus on adoption of AI-enabled portable diagnostic devices, mobile health applications, and cloud-based platforms for cardiac data analysis.

Many healthcare providers rely on partnerships with multinational technology companies and NGOs to deploy AI solutions tailored to local needs. The competitive landscape is less saturated, offering opportunities for emerging startups and foreign technology firms to establish presence. Challenges include limited regulatory frameworks, funding constraints, and workforce shortages in both cardiology and AI specialties. Nonetheless, increasing government interest in digital transformation and healthcare modernization projects suggest a positive trajectory. Capacity building through training and knowledge exchange is a critical enabler for market growth.               In conclusion, North America stands at the forefront of leveraging AI to revolutionize cardiology care, improving patient outcomes while addressing healthcare system challenges such as cost containment and specialist shortages.

Free Valuable Insights: The Artificial Intelligence In Cardiology Market is Predict to reach USD 18.21 Billion by 2032, at a CAGR of 32.3%

Based on Component, the market is segmented into Hardware, Software, and Services. Based on Application, the market is segmented into Diagnosis, Prediction, Drug Discovery, and Other Application. Based on Medical Condition, the market is segmented into Ischemic Heart Disease /CAD, Cardiac Arrhythmias, Heart Failure, and Other Medical Condition. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• IDOVEN S.L.
• Ultromics Ltd.
• CardiAI.Inc.
• Tempus AI, Inc.
• Koninklijke Philips N.V.
• Cleerly, Inc.
• Vista AI, Inc.
• Viz.ai, Inc.
• RSIP Vision Ltd.
• GE HealthCare Technologies, Inc.

North America Artificial Intelligence In Cardiology Market Report Segmentation

By Component

• Hardware
• Software
• Services

By Application

• Diagnosis
• Prediction
• Drug Discovery
• Other Application

By Medical Condition

• Ischemic Heart Disease /CAD
• Cardiac Arrhythmias
• Heart Failure
• Other Medical Condition

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence In Cardiology Market, by Component
1.4.2 North America Artificial Intelligence In Cardiology Market, by Application
1.4.3 North America Artificial Intelligence In Cardiology Market, by Medical Condition
1.4.4 North America Artificial Intelligence In Cardiology Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. Value Chain Analysis of Artificial Intelligence In Cardiology Market
5.1 Research & Development (R&D):
5.2 Data Acquisition & Management:
5.3 Model Development & Training:
5.4 Regulatory Approval & Certification:
5.5 Product Integration & Deployment:
5.6 Marketing & Sales:
5.7 After-Sales Support & Feedback Loop:

Chapter 6. Key Customer Criteria - Artificial Intelligence In Cardiology Market
6.1 Diagnostic Accuracy
6.2 Regulatory Compliance
6.3 Data Privacy and Security
6.4 Integration with Existing Healthcare Systems
6.5 Clinical Validation and Peer-Reviewed Evidence
6.6 Ease of Use and Interface Design
6.7 Real-Time Processing and Speed
6.8 Cost-Effectiveness and Return on Investment (ROI)
6.9 Continuous Learning and Model Updates
6.10. Vendor Support and Training Services

Chapter 7. North America Artificial Intelligence In Cardiology Market by Component
7.1 North America Hardware Market by Country
7.2 North America Software Market by Country
7.3 North America Services Market by Country

Chapter 8. North America Artificial Intelligence In Cardiology Market by Application
8.1 North America Diagnosis Market by Country
8.2 North America Prediction Market by Country
8.3 North America Drug Discovery Market by Country
8.4 North America Other Application Market by Country

Chapter 9. North America Artificial Intelligence In Cardiology Market by Medical Condition
9.1 North America Ischemic Heart Disease /CAD Market by Country
9.2 North America Cardiac Arrhythmias Market by Country
9.3 North America Heart Failure Market by Country
9.4 North America Other Medical Condition Market by Country

Chapter 10. North America Artificial Intelligence In Cardiology Market by Country
10.1 US Artificial Intelligence In Cardiology Market
10.1.1 US Artificial Intelligence In Cardiology Market by Component
10.1.2 US Artificial Intelligence In Cardiology Market by Application
10.1.3 US Artificial Intelligence In Cardiology Market by Medical Condition
10.2 Canada Artificial Intelligence In Cardiology Market
10.2.1 Canada Artificial Intelligence In Cardiology Market by Component
10.2.2 Canada Artificial Intelligence In Cardiology Market by Application
10.2.3 Canada Artificial Intelligence In Cardiology Market by Medical Condition
10.3 Mexico Artificial Intelligence In Cardiology Market
10.3.1 Mexico Artificial Intelligence In Cardiology Market by Component
10.3.2 Mexico Artificial Intelligence In Cardiology Market by Application
10.3.3 Mexico Artificial Intelligence In Cardiology Market by Medical Condition
10.4 Rest of North America Artificial Intelligence In Cardiology Market
10.4.1 Rest of North America Artificial Intelligence In Cardiology Market by Component
10.4.2 Rest of North America Artificial Intelligence In Cardiology Market by Application
10.4.3 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition

Chapter 11. Company Profiles
11.1 IDOVEN S.L.
11.1.1 Company Overview
11.2 Ultromics Ltd.
11.2.1 Company Overview
11.2.2 Recent strategies and developments:
11.2.2.1 Partnerships, Collaborations, and Agreements:
11.2.2.2 Product Launches and Product Expansions:
11.3 CardiAI Inc.
11.3.1 Company Overview
11.4 Tempus AI, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Research & Development Expenses
11.4.4 Recent strategies and developments:
11.4.4.1 Product Launches and Product Expansions:
11.4.4.2 Acquisition and Mergers:
11.4.5 SWOT Analysis
11.5 Koninklijke Philips N.V.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Cleerly, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Partnerships, Collaborations, and Agreements:
11.7 Vista AI, Inc.
11.7.1 Company Overview
11.8 Viz.ai, Inc.
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.2.2 Product Launches and Product Expansions:
11.9 RSIP Vision Ltd.
11.9.1 Company Overview
11.10. GE HealthCare Technologies, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expenses
11.10.5 Recent strategies and developments:
11.10.5.1 Product Launches and Product Expansions:
11.10.6 SWOT Analysis

TABLE 1 North America Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 2 North America Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Artificial Intelligence In Cardiology Market
TABLE 4 Product Launches And Product Expansions– Artificial Intelligence In Cardiology Market
TABLE 5 Acquisition and Mergers– Artificial Intelligence In Cardiology Market
TABLE 6 Key Customer Criteria - Artificial Intelligence In Cardiology Market
TABLE 7 North America Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 8 North America Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 9 North America Hardware Market by Country, 2021 - 2024, USD Million
TABLE 10 North America Hardware Market by Country, 2025 - 2032, USD Million
TABLE 11 North America Software Market by Country, 2021 - 2024, USD Million
TABLE 12 North America Software Market by Country, 2025 - 2032, USD Million
TABLE 13 North America Services Market by Country, 2021 - 2024, USD Million
TABLE 14 North America Services Market by Country, 2025 - 2032, USD Million
TABLE 15 North America Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 16 North America Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 17 North America Diagnosis Market by Country, 2021 - 2024, USD Million
TABLE 18 North America Diagnosis Market by Country, 2025 - 2032, USD Million
TABLE 19 North America Prediction Market by Country, 2021 - 2024, USD Million
TABLE 20 North America Prediction Market by Country, 2025 - 2032, USD Million
TABLE 21 North America Drug Discovery Market by Country, 2021 - 2024, USD Million
TABLE 22 North America Drug Discovery Market by Country, 2025 - 2032, USD Million
TABLE 23 North America Other Application Market by Country, 2021 - 2024, USD Million
TABLE 24 North America Other Application Market by Country, 2025 - 2032, USD Million
TABLE 25 North America Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 26 North America Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 27 North America Ischemic Heart Disease /CAD Market by Country, 2021 - 2024, USD Million
TABLE 28 North America Ischemic Heart Disease /CAD Market by Country, 2025 - 2032, USD Million
TABLE 29 North America Cardiac Arrhythmias Market by Country, 2021 - 2024, USD Million
TABLE 30 North America Cardiac Arrhythmias Market by Country, 2025 - 2032, USD Million
TABLE 31 North America Heart Failure Market by Country, 2021 - 2024, USD Million
TABLE 32 North America Heart Failure Market by Country, 2025 - 2032, USD Million
TABLE 33 North America Other Medical Condition Market by Country, 2021 - 2024, USD Million
TABLE 34 North America Other Medical Condition Market by Country, 2025 - 2032, USD Million
TABLE 35 North America Artificial Intelligence In Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 36 North America Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 37 US Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 38 US Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 39 US Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 40 US Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 41 US Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 42 US Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 43 US Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 44 US Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 45 Canada Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 46 Canada Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 47 Canada Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 48 Canada Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 49 Canada Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 50 Canada Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 51 Canada Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 52 Canada Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 53 Mexico Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 54 Mexico Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 55 Mexico Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 56 Mexico Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 57 Mexico Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 58 Mexico Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 59 Mexico Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 60 Mexico Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 61 Rest of North America Artificial Intelligence In Cardiology Market, 2021 - 2024, USD Million
TABLE 62 Rest of North America Artificial Intelligence In Cardiology Market, 2025 - 2032, USD Million
TABLE 63 Rest of North America Artificial Intelligence In Cardiology Market by Component, 2021 - 2024, USD Million
TABLE 64 Rest of North America Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
TABLE 65 Rest of North America Artificial Intelligence In Cardiology Market by Application, 2021 - 2024, USD Million
TABLE 66 Rest of North America Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
TABLE 67 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition, 2021 - 2024, USD Million
TABLE 68 Rest of North America Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
TABLE 69 Key Information – IDOVEN S.L.
TABLE 70 Key Information – Ultromics Ltd.
TABLE 71 Key Information – CardiAI Inc.
TABLE 72 Key Information – Tempus AI, Inc.
TABLE 73 Key Information – Koninklijke Philips N.V.
TABLE 74 Key Information – Cleerly, Inc.
TABLE 75 Key Information – Vista AI, Inc.
TABLE 76 Key Information – Viz.ai, Inc.
TABLE 77 Key Information – RSIP Vision Ltd.
TABLE 78 Key Information – GE HealthCare Technologies, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Artificial Intelligence In Cardiology Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Artificial Intelligence In Cardiology Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2024
FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
FIG 7 Key Strategic Move: (Product Launches and Product Expansions : 2021, Nov – 2025, Apr) Leading Players
FIG 8 Porter Five Forces Analysis - Artificial Intelligence In Cardiology Market
FIG 9 Value Chain Analysis of Artificial Intelligence In Cardiology Market
FIG 10 Key Customer Criteria - Artificial Intelligence In Cardiology Market
FIG 11 North America Artificial Intelligence In Cardiology Market share by Component, 2024
FIG 12 North America Artificial Intelligence In Cardiology Market share by Component, 2032
FIG 13 North America Artificial Intelligence In Cardiology Market by Component, 2025 - 2032, USD Million
FIG 14 North America Artificial Intelligence In Cardiology Market share by Application, 2024
FIG 15 North America Artificial Intelligence In Cardiology Market share by Application, 2032
FIG 16 North America Artificial Intelligence In Cardiology Market by Application, 2025 - 2032, USD Million
FIG 17 North America Artificial Intelligence In Cardiology Market share by Medical Condition, 2024
FIG 18 North America Artificial Intelligence In Cardiology Market share by Medical Condition, 2032
FIG 19 North America Artificial Intelligence In Cardiology Market by Medical Condition, 2025 - 2032, USD Million
FIG 20 North America Artificial Intelligence In Cardiology Market share by Country, 2024
FIG 21 North America Artificial Intelligence In Cardiology Market share by Country, 2032
FIG 22 North America Artificial Intelligence In Cardiology Market by Country, 2025 - 2032, USD Million
FIG 23 Recent strategies and developments: Ultromics Ltd.
FIG 24 Recent strategies and developments: Tempus AI, Inc.
FIG 25 SWOT Analysis: Tempus AI, Inc.
FIG 26 Recent strategies and developments: Koninklijke Philips N.V.
FIG 27 SWOT Analysis: Koninklijke Philips N.V.
FIG 28 Recent strategies and developments: Viz.ai, Inc.
FIG 29 SWOT Analysis: GE HealthCare Technologies, Inc.